Seeking Alpha

Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference

Please reach out to your Barclays representative to schedule a one-on-one meeting. About Alpha Tau Medical Ltd. Founded in 2016, Alpha Tau is an Israeli medical device company that focuses on research ...
Seeking Alpha

Alpha Tau to Participate in December Investor Conferences

Mr. Levy will be available for 1x1 investor meetings at both conferences. Please reach out to your Piper Sandler and Sidoti representatives to schedule. About Alpha Tau Medical Ltd. Founded in 2016, ...

HekaBio and Alpha Tau Medical Obtain Approval in Japan for Solid Tumor Treatment Alpha DaRT

HekaBio K.K., (Headquarters: Chuo-ku, Tokyo) announces that the innovative solid tumor treatment device ‘Alpha DaRT ...

Alpha Tau Medical Receives Japanese Marketing Approval for Alpha DaRT® in Unresectable Locally Advanced or Locally Recurrent Head and Neck Cancer

Approval establishes first clinical authorization outside Israel and initiates post-market surveillance program - - First-in-kind technology delivers intra-tumoral alpha-emitting radiotherapeutics, ...
Nasdaq

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma

JERUSALEM, April 02, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, announced today that the FDA has ...
Nasdaq

Alpha Tau Medical Achieves MDSAP Certification for Jerusalem Manufacturing Facility

Alpha Tau Medical Ltd. announced that it has achieved Medical Device Single Audit Program (MDSAP) certification for its manufacturing facility in Jerusalem, which is a key step in ensuring quality, ...
Business Insider

Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT® for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC)

- Initial module submission marks an important milestone in the pre-market approval process - - Flexible modular submission framework granted to Alpha Tau by the FDA allows for streamlined review and ...

Alpha Tau Issues Letter to Shareholders: Five Concurrent Trials in the U.S. with Multiple Significant Value-Driving Milestones Ahead

Expecting very active 2026 from a clinical perspective, including significant patient accrual completions and subsequent data ...
Business Insider

Alpha Tau announces acceptance into FDA’s TPLC TAP Pilot

Alpha Tau (DRTS) Medical announced that it has been accepted into the prestigious Total Product Life Cycle, TPLC, Advisory Program, TAP, Pilot of the U.S. Food and Drug Administration, FDA, to ...
MarketWatch

Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT(R) for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC)

The MarketWatch News Department was not involved in the creation of this content. - Initial module submission marks an important milestone in the pre-market approval process - - Flexible modular ...